MedImmune (development and commercial rights of HMGB1) is Buildings and Property in United States that focus on endogenous mediator business. They cover business area such as a right, high-mobility group box protein, gene transcription, nucleosome formation, tissue injury, pro-inflammatory cytokine.
-
Endogenous Mediator
-
MD
United States
Private
a righthigh-mobility group box proteingene transcriptionnucleosome formationtissue injurypro-inflammatory cytokine
* We use standard office opening hours in near MedImmune (development and commercial rights of HMGB1)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
MedImmune (development And Commercial Rights Of HMGB1) is Buildings and Property business from United States that founded in - ( years old in ), MedImmune (development and commercial rights of HMGB1) business is focusing on Endogenous Mediator.
MedImmune (development and commercial rights of HMGB1) headquarter office and corporate office address is located in MD United States.
MedImmune (development and commercial rights of HMGB1) was founded in United States.
In , MedImmune (development and commercial rights of HMGB1) is currently focus on endogenous mediator sector.
Above is snippet of Google Trends for "endogenous mediator" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with MedImmune (development and commercial rights of HMGB1), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
